RPG Life Sciences Limited
NSE:RPGLIFE.NS
Overview | Financials
Company Name | RPG Life Sciences Limited |
Symbol | RPGLIFE.NS |
Currency | INR |
Price | 2,260.05 |
Market Cap | 37,378,966,950 |
Dividend Yield | 0.82% |
52-week-range | 1,138.55 - 2,422 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yugal Kishor Choturam Sikri |
Website | https://www.rpglifesciences.com |
An error occurred while fetching data.
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD